You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Expanding Scope of Post-transplant HLA-specific Antibody

Not yet recruiting
  • Kidney Transplant
  • +7 more
  • cf-DNA
  • +2 more
  • Liverpool, Merseyside, United Kingdom
    Liverpool University Hospitals NHS Foundation Trust
Aug 29, 2023

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023

Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)

Not yet recruiting
  • Hematologic Malignancies
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 5, 2023

Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Recruiting
  • Graft Rejection
  • +3 more
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
Jun 21, 2023

Early Detection of Endotheliopathy Post-Transplant

Recruiting
  • Endotheliopathy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jan 18, 2023

    Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

    Recruiting
    • Transplant-Related Hematologic Malignancy
    • Atlanta, Georgia
      Northside Hospital
    Oct 19, 2022

    Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2023

    Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

    Recruiting
    • Myeloproliferative Neoplasm
    • Fedratinib Pill
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2022

    Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

    Not yet recruiting
    • Hematological Malignancies
    • Allogeneic T cell progenitors, cultured ex-vivo
    • (no location specified)
    Mar 2, 2023

    Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

    Active, not recruiting
    • Chronic Granulomatous Disease Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

    Not yet recruiting
    • Bone Marrow Transplant Complications
    • +4 more
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    May 30, 2023

    Focal Segmental Glomerulosclerosis and Minimal Change Disease

    Not yet recruiting
    • Focal Segmental Glomerulosclerosis
    • +3 more
    • Biospecimen collection
    • Data collection
    • Ann Arbor, Michigan
      University of Michigan
    Dec 6, 2022

    Immune Reconstitution After Allo-HSCT and Blinatumomab

    Not yet recruiting
    • Leukemia, Lymphoid
    • (no location specified)
    Oct 3, 2023

    Influence of Timing PTCy in AlloSCT

    Not yet recruiting
    • Cyclophosphamide Toxicity
    • Allogenic Haematopoetic Transplantation
    • (no location specified)
    Jun 6, 2023

    Hematologic Malignancy Trial (Cyclophosphamid, ATG)

    Not yet recruiting
    • Hematologic Malignancy
    • (no location specified)
    Oct 29, 2023

    Penpulimab in Maintenance Therapy in Lymphoma

    Not yet recruiting
    • Lymphoma
    • (no location specified)
    Dec 25, 2022

    Post-transplant Diabetes, New Onset Diabetes After Transplant, New Onset Diabetes After Transplantation Trial in London

    Completed
    • Post-transplant Diabetes Mellitus
    • +6 more
    • London, United Kingdom
      Royal London Hospital, Barts Health NHS Trust
    Oct 17, 2022

    Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

    Recruiting
    • Myelofibrosis
    • +2 more
    • Charlottesville, Virginia
      Danyelle Coley
    Jan 18, 2023

    Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jan 10, 2023

    Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

    Suspended
    • Hematologic Malignancies
    • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
    • La Jolla, California
      UCSD Medical Center
    Jul 20, 2022

    Liver Transplant; Complications, Vitamin D Deficiency Trial (vitamin D supplementation, control)

    Not yet recruiting
    • Liver Transplant; Complications
    • Vitamin D Deficiency
    • vitamin D supplementation
    • control
    • (no location specified)
    Oct 5, 2022

    GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

    Recruiting
    • Graft Versus Host Disease
    • Ramat Gan, Israel
      Chaim Sheba Medical Center
    May 4, 2022